HKD 1.5
(-0.66%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 16.64 Billion CNY | 19.43% |
2022 | 13.93 Billion CNY | 46.08% |
2021 | 9.53 Billion CNY | 53.17% |
2020 | 6.22 Billion CNY | -2.03% |
2019 | 6.35 Billion CNY | 9.82% |
2018 | 5.78 Billion CNY | 12.43% |
2017 | 5.14 Billion CNY | -25.92% |
2016 | 6.94 Billion CNY | -17.46% |
2015 | 8.41 Billion CNY | 6.1% |
2014 | 7.93 Billion CNY | 72.25% |
2013 | 4.6 Billion CNY | 76.43% |
2012 | 2.61 Billion CNY | 32.19% |
2011 | 1.97 Billion CNY | 64.3% |
2010 | 1.2 Billion CNY | -14.3% |
2009 | 1.4 Billion CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 16.96 Billion CNY | 0.0% |
2023 Q2 | 16.37 Billion CNY | 0.0% |
2023 FY | 16.64 Billion CNY | 19.43% |
2023 Q4 | 16.64 Billion CNY | 0.0% |
2022 Q2 | 12.02 Billion CNY | 0.0% |
2022 Q4 | 13.93 Billion CNY | 0.0% |
2022 FY | 13.93 Billion CNY | 46.08% |
2021 Q2 | 7.73 Billion CNY | 0.0% |
2021 FY | 9.53 Billion CNY | 53.17% |
2021 Q4 | 9.53 Billion CNY | 0.0% |
2020 Q2 | 8.56 Billion CNY | 0.0% |
2020 FY | 6.22 Billion CNY | -2.03% |
2020 Q4 | 6.22 Billion CNY | 0.0% |
2019 FY | 6.35 Billion CNY | 9.82% |
2019 Q4 | 6.35 Billion CNY | 0.0% |
2019 Q2 | 6.32 Billion CNY | 0.0% |
2018 Q2 | 5.74 Billion CNY | 0.0% |
2018 FY | 5.78 Billion CNY | 12.43% |
2018 Q4 | 5.78 Billion CNY | 0.0% |
2017 Q2 | 6.25 Billion CNY | 0.0% |
2017 FY | 5.14 Billion CNY | -25.92% |
2017 Q4 | 5.14 Billion CNY | 0.0% |
2016 Q2 | 7.93 Billion CNY | 0.0% |
2016 FY | 6.94 Billion CNY | -17.46% |
2016 Q4 | 6.94 Billion CNY | 0.0% |
2015 FY | 8.41 Billion CNY | 6.1% |
2015 Q2 | 9.29 Billion CNY | 0.0% |
2015 Q4 | 8.41 Billion CNY | 0.0% |
2014 Q4 | 7.93 Billion CNY | 0.0% |
2014 Q2 | 8.23 Billion CNY | 0.0% |
2014 FY | 7.93 Billion CNY | 72.25% |
2013 FY | 4.6 Billion CNY | 76.43% |
2013 Q4 | 4.6 Billion CNY | 0.0% |
2013 Q2 | 4.35 Billion CNY | 0.0% |
2012 Q4 | 2.61 Billion CNY | 0.0% |
2012 FY | 2.61 Billion CNY | 32.19% |
2012 Q2 | 2.28 Billion CNY | 0.0% |
2011 FY | 1.97 Billion CNY | 64.3% |
2011 Q2 | 1.52 Billion CNY | 0.0% |
2011 Q4 | 1.97 Billion CNY | 0.0% |
2010 Q2 | 1.51 Billion CNY | 0.0% |
2010 FY | 1.2 Billion CNY | -14.3% |
2010 Q4 | 1.2 Billion CNY | 0.0% |
2009 Q4 | 1.4 Billion CNY | 0.0% |
2009 FY | 1.4 Billion CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 229.69 Million HKD | -7144.671% |
Lee & Man Chemical Company Limited | 1.22 Billion HKD | -1253.748% |